CYP19A1 and breast cancer: Gnant Gnant M M Fitzal Fitzal F F Rinnerthaler Rinnerthaler G G Steger Steger GG GG Greil-Ressler Greil-Ressler S S Balic Balic M M Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer N Engl J Med N Engl J Med 2021 2021 385 385 5 5 395 395 405 405 10.1056/NEJMoa2104162 10.1056/NEJMoa2104162 supplied-pmid 34320285?